Mersana Therapeutics, Inc. (MRSN)

NASDAQ: MRSN · IEX Real-Time Price · USD

1.860

-0.110 (-5.58%)

At close: Jul 2, 2024, 4:00 PM

1.900

+0.040 (2.15%)

After-hours: Jul 2, 2024, 4:37 PM EDT

Mersana Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Net Income	-171.67	-204.21	-170.06	-88.05	-28.21	Upgrade
Depreciation & Amortization	4.3	3.7	2.68	1.01	1.25	Upgrade
Share-Based Compensation	21.14	21.52	18.41	7.17	4.87	Upgrade
Other Operating Activities	-22.65	129.62	8.98	5.17	-45.65	Upgrade
Operating Cash Flow	-168.88	-49.36	-139.99	-74.7	-67.74	Upgrade
Capital Expenditures	-2.17	-2.2	-0.65	-0.47	-0.61	Upgrade
Change in Investments	122.05	-150.52	0	37.5	-26.69	Upgrade
Investing Cash Flow	119.88	-152.72	-0.65	37.03	-27.29	Upgrade
Share Issuance / Repurchase	95.09	153.29	45.56	230.73	92.83	Upgrade
Debt Issued / Paid	-0.41	-0.27	18.34	-0.31	4.88	Upgrade
Other Financing Activities	-	-	-0.26	-	-	Upgrade
Financing Cash Flow	94.68	153.02	63.65	230.41	97.7	Upgrade
Net Cash Flow	45.68	-49.06	-76.99	192.74	2.67	Upgrade
Free Cash Flow	-171.05	-51.56	-140.64	-75.17	-68.35	Upgrade
Free Cash Flow Margin	-464.12%	-193.97%	-327060.47%	-9078.38%	-162.26%	Upgrade
Free Cash Flow Per Share	-1.47	-0.55	-1.99	-1.22	-1.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).